HLA-DRB1 and myeloid sarcoma: Previous studies in IFN-beta–treated MS patients and in anti-TNF–treated IBD and RA patients have shown association of ADAs with HLA-DRB1 alleles, with specific alleles for each disease and BP potentially suggesting different capacity to present BP-specific peptides to T cells [43,44].